PMV Pharmaceuticals PMVP
NASDAQ PMVP
$1.43 +0.07 (+5.15%)
At close: Sep 29, 2026 · 4:00 PM EDT

PMV Pharmaceuticals (PMVP) Total Current Liabilities (2019 - 2026)

Updated

PMV Pharmaceuticals' Total Current Liabilities came in at $10.57 million for Q2 2026, down 9.0% from $11.61 million a year earlier but up 23.0% from the prior quarter.

Analysis

PMV Pharmaceuticals (PMVP) Total Current Liabilities (2019 - 2026) Analysis & Trends

At the end of FY2025, PMV Pharmaceuticals' Total Current Liabilities was $11.42 million, down 20.6% from FY2024.

  • Total Current Liabilities carries a five-year compound annual growth rate of 12.2% (FY2020 to FY2025).
  • Going back by year, Total Current Liabilities was $14.37 million in FY2024 (+2.4%), $14.03 million in FY2023 (+29.5%), $10.83 million in FY2022 (-11.4%) and $12.22 million in FY2021 (+90.6%).
  • The five-year range for quarterly Total Current Liabilities is $8.56 million (Q3 2021) to $14.37 million (Q4 2024).
  • Year-over-year, Total Current Liabilities has declined for four consecutive quarters, with an average decline of 4.9% over the last eight quarters.
  • The fastest year-over-year change in Total Current Liabilities over five years came in Q1 2022 (growth of 101.6%), and the weakest in Q4 2025 (a decline of 20.6%).
  • Business Quant data shows PMVP's Total Current Liabilities at $8.6 million (Q1 2026), $11.42 million (Q4 2025) and $12.3 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 PMV Pharmaceuticals 72.71 Mn -342.47 Mn - 10.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.57 Mn
Mar 31, 2026 8.60 Mn
Dec 31, 2025 11.42 Mn
Sep 30, 2025 12.30 Mn
Jun 30, 2025 11.61 Mn
Mar 31, 2025 9.76 Mn
Dec 31, 2024 14.37 Mn
Sep 30, 2024 13.56 Mn
Jun 30, 2024 11.39 Mn
Mar 31, 2024 12.06 Mn
Dec 31, 2023 14.03 Mn
Sep 30, 2023 10.72 Mn
Jun 30, 2023 11.45 Mn
Mar 31, 2023 10.59 Mn
Dec 31, 2022 10.83 Mn
Sep 30, 2022 11.66 Mn
Jun 30, 2022 11.38 Mn
Mar 31, 2022 11.69 Mn
Dec 31, 2021 12.22 Mn
Sep 30, 2021 8.56 Mn
API Access

PMV Pharmaceuticals Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=PMVP&period=max&api_key=YOUR_API_KEY